Longitudinal Observation of Insulin Use and Glucose Sensor Metrics in Pregnant Women with Type 1 Diabetes Using Continuous Glucose Monitors and Insulin Pumps: The LOIS-P Study
العنوان: | Longitudinal Observation of Insulin Use and Glucose Sensor Metrics in Pregnant Women with Type 1 Diabetes Using Continuous Glucose Monitors and Insulin Pumps: The LOIS-P Study |
---|---|
المؤلفون: | Carol J. Levy, Barak Rosenn, Donna Desjardins, Jordan E. Pinsker, Corey Reid, Mei Mei Church, Yogish C. Kudva, Mari Charisse Trinidad, Kristin Castorino, Francis J. Doyle, Walter K. Kremers, Shelly K. McCrady-Spitzer, Eyal Dassau, Ravinder Kaur, Camilla Levister, Basak Ozaslan, Grenye O’Malley |
المصدر: | Diabetes Technol Ther |
بيانات النشر: | Mary Ann Liebert, Inc., publishers, 2021. |
سنة النشر: | 2021 |
مصطلحات موضوعية: | Blood Glucose, Pediatrics, medicine.medical_specialty, Endocrinology, Diabetes and Metabolism, medicine.medical_treatment, Longitudinal observation, Endocrinology, Pregnancy, Diabetes mellitus, medicine, Humans, Hypoglycemic Agents, Insulin, Glycemic, Type 1 diabetes, business.industry, Blood Glucose Self-Monitoring, Infant, Newborn, Infant, Original Articles, medicine.disease, INSULIN USE, Medical Laboratory Technology, Benchmarking, Diabetes Mellitus, Type 1, Female, Pregnant Women, Glucose monitors, business |
الوصف: | BACKGROUND: Suboptimal glycemic control is associated with maternal and neonatal morbidity and mortality in pregnancy complicated by type 1 diabetes (T1D). Prospective analysis of continuous glucose monitoring (CGM) metrics, insulin pump settings, and insulin delivery can better characterize the changes in glycemic levels and insulin use throughout pregnancy with T1D. MATERIALS AND METHODS: Prescribed parameters, insulin delivery, carbohydrate intake, and CGM data for 25 pregnant women with T1D from three U.S. sites were collected. Participants enrolled before 17 weeks gestation and used personal insulin pumps and study CGM. Mean daily total, basal, and bolus insulin doses (units/kg), CGM time in range (TIR: 63–140 mg/dL), and pump-entered carbohydrates were analyzed for every 2-week gestational interval. Linear mixed-effects regression models were used to evaluate changes across gestational ages compared to 12–14 weeks. RESULTS: Basal insulin was higher during weeks 6–12 and 24–40. Daily bolus and total insulin were higher during weeks 20–40. Pump parameters were adjusted to intensify insulin therapy from 22 weeks onward. Average TIR across pregnancy was 59% ± 14%. Between 18 and 30 weeks, TIR was significantly lower, and time above range was significantly higher compared to the reference biweek. Time below target was lower between 22 and 34 weeks. Seven participants achieved >70% recommended TIR for pregnancy. Participants with maternal complications or infant neonatal intensive care unit admissions had lower TIR. CONCLUSION: While insulin dosing changed significantly with advancing gestation, most participants did not achieve >70% TIR. Customized anticipatory pump setting adjustments and automated systems aimed toward the designated TIR are needed to improve outcomes for this population. NCT03761615 |
اللغة: | English |
الوصول الحر: | https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c8c0c21b28b4fe873ed934b6c5bbba25Test https://europepmc.org/articles/PMC9057877Test/ |
حقوق: | OPEN |
رقم الانضمام: | edsair.doi.dedup.....c8c0c21b28b4fe873ed934b6c5bbba25 |
قاعدة البيانات: | OpenAIRE |
ResultId |
1 |
---|---|
Header |
edsair OpenAIRE edsair.doi.dedup.....c8c0c21b28b4fe873ed934b6c5bbba25 873 3 unknown 872.854125976563 |
PLink |
https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....c8c0c21b28b4fe873ed934b6c5bbba25&custid=s6537998&authtype=sso |
FullText |
Array
(
[Availability] => 0
)
|
Items |
Array
(
[Name] => Title
[Label] => Title
[Group] => Ti
[Data] => Longitudinal Observation of Insulin Use and Glucose Sensor Metrics in Pregnant Women with Type 1 Diabetes Using Continuous Glucose Monitors and Insulin Pumps: The LOIS-P Study
)
Array ( [Name] => Author [Label] => Authors [Group] => Au [Data] => <searchLink fieldCode="AR" term="%22Carol+J%2E+Levy%22">Carol J. Levy</searchLink><br /><searchLink fieldCode="AR" term="%22Barak+Rosenn%22">Barak Rosenn</searchLink><br /><searchLink fieldCode="AR" term="%22Donna+Desjardins%22">Donna Desjardins</searchLink><br /><searchLink fieldCode="AR" term="%22Jordan+E%2E+Pinsker%22">Jordan E. Pinsker</searchLink><br /><searchLink fieldCode="AR" term="%22Corey+Reid%22">Corey Reid</searchLink><br /><searchLink fieldCode="AR" term="%22Mei+Mei+Church%22">Mei Mei Church</searchLink><br /><searchLink fieldCode="AR" term="%22Yogish+C%2E+Kudva%22">Yogish C. Kudva</searchLink><br /><searchLink fieldCode="AR" term="%22Mari+Charisse+Trinidad%22">Mari Charisse Trinidad</searchLink><br /><searchLink fieldCode="AR" term="%22Kristin+Castorino%22">Kristin Castorino</searchLink><br /><searchLink fieldCode="AR" term="%22Francis+J%2E+Doyle%22">Francis J. Doyle</searchLink><br /><searchLink fieldCode="AR" term="%22Walter+K%2E+Kremers%22">Walter K. Kremers</searchLink><br /><searchLink fieldCode="AR" term="%22Shelly+K%2E+McCrady-Spitzer%22">Shelly K. McCrady-Spitzer</searchLink><br /><searchLink fieldCode="AR" term="%22Eyal+Dassau%22">Eyal Dassau</searchLink><br /><searchLink fieldCode="AR" term="%22Ravinder+Kaur%22">Ravinder Kaur</searchLink><br /><searchLink fieldCode="AR" term="%22Camilla+Levister%22">Camilla Levister</searchLink><br /><searchLink fieldCode="AR" term="%22Basak+Ozaslan%22">Basak Ozaslan</searchLink><br /><searchLink fieldCode="AR" term="%22Grenye+O%27Malley%22">Grenye O’Malley</searchLink> ) Array ( [Name] => TitleSource [Label] => Source [Group] => Src [Data] => Diabetes Technol Ther ) Array ( [Name] => Publisher [Label] => Publisher Information [Group] => PubInfo [Data] => Mary Ann Liebert, Inc., publishers, 2021. ) Array ( [Name] => DatePubCY [Label] => Publication Year [Group] => Date [Data] => 2021 ) Array ( [Name] => Subject [Label] => Subject Terms [Group] => Su [Data] => <searchLink fieldCode="DE" term="%22Blood+Glucose%22">Blood Glucose</searchLink><br /><searchLink fieldCode="DE" term="%22Pediatrics%22">Pediatrics</searchLink><br /><searchLink fieldCode="DE" term="%22medicine%2Emedical%5Fspecialty%22">medicine.medical_specialty</searchLink><br /><searchLink fieldCode="DE" term="%22Endocrinology%2C+Diabetes+and+Metabolism%22">Endocrinology, Diabetes and Metabolism</searchLink><br /><searchLink fieldCode="DE" term="%22medicine%2Emedical%5Ftreatment%22">medicine.medical_treatment</searchLink><br /><searchLink fieldCode="DE" term="%22Longitudinal+observation%22">Longitudinal observation</searchLink><br /><searchLink fieldCode="DE" term="%22Endocrinology%22">Endocrinology</searchLink><br /><searchLink fieldCode="DE" term="%22Pregnancy%22">Pregnancy</searchLink><br /><searchLink fieldCode="DE" term="%22Diabetes+mellitus%22">Diabetes mellitus</searchLink><br /><searchLink fieldCode="DE" term="%22medicine%22">medicine</searchLink><br /><searchLink fieldCode="DE" term="%22Humans%22">Humans</searchLink><br /><searchLink fieldCode="DE" term="%22Hypoglycemic+Agents%22">Hypoglycemic Agents</searchLink><br /><searchLink fieldCode="DE" term="%22Insulin%22">Insulin</searchLink><br /><searchLink fieldCode="DE" term="%22Glycemic%22">Glycemic</searchLink><br /><searchLink fieldCode="DE" term="%22Type+1+diabetes%22">Type 1 diabetes</searchLink><br /><searchLink fieldCode="DE" term="%22business%2Eindustry%22">business.industry</searchLink><br /><searchLink fieldCode="DE" term="%22Blood+Glucose+Self-Monitoring%22">Blood Glucose Self-Monitoring</searchLink><br /><searchLink fieldCode="DE" term="%22Infant%2C+Newborn%22">Infant, Newborn</searchLink><br /><searchLink fieldCode="DE" term="%22Infant%22">Infant</searchLink><br /><searchLink fieldCode="DE" term="%22Original+Articles%22">Original Articles</searchLink><br /><searchLink fieldCode="DE" term="%22medicine%2Edisease%22">medicine.disease</searchLink><br /><searchLink fieldCode="DE" term="%22INSULIN+USE%22">INSULIN USE</searchLink><br /><searchLink fieldCode="DE" term="%22Medical+Laboratory+Technology%22">Medical Laboratory Technology</searchLink><br /><searchLink fieldCode="DE" term="%22Benchmarking%22">Benchmarking</searchLink><br /><searchLink fieldCode="DE" term="%22Diabetes+Mellitus%2C+Type+1%22">Diabetes Mellitus, Type 1</searchLink><br /><searchLink fieldCode="DE" term="%22Female%22">Female</searchLink><br /><searchLink fieldCode="DE" term="%22Pregnant+Women%22">Pregnant Women</searchLink><br /><searchLink fieldCode="DE" term="%22Glucose+monitors%22">Glucose monitors</searchLink><br /><searchLink fieldCode="DE" term="%22business%22">business</searchLink> ) Array ( [Name] => Abstract [Label] => Description [Group] => Ab [Data] => BACKGROUND: Suboptimal glycemic control is associated with maternal and neonatal morbidity and mortality in pregnancy complicated by type 1 diabetes (T1D). Prospective analysis of continuous glucose monitoring (CGM) metrics, insulin pump settings, and insulin delivery can better characterize the changes in glycemic levels and insulin use throughout pregnancy with T1D. MATERIALS AND METHODS: Prescribed parameters, insulin delivery, carbohydrate intake, and CGM data for 25 pregnant women with T1D from three U.S. sites were collected. Participants enrolled before 17 weeks gestation and used personal insulin pumps and study CGM. Mean daily total, basal, and bolus insulin doses (units/kg), CGM time in range (TIR: 63–140 mg/dL), and pump-entered carbohydrates were analyzed for every 2-week gestational interval. Linear mixed-effects regression models were used to evaluate changes across gestational ages compared to 12–14 weeks. RESULTS: Basal insulin was higher during weeks 6–12 and 24–40. Daily bolus and total insulin were higher during weeks 20–40. Pump parameters were adjusted to intensify insulin therapy from 22 weeks onward. Average TIR across pregnancy was 59% ± 14%. Between 18 and 30 weeks, TIR was significantly lower, and time above range was significantly higher compared to the reference biweek. Time below target was lower between 22 and 34 weeks. Seven participants achieved >70% recommended TIR for pregnancy. Participants with maternal complications or infant neonatal intensive care unit admissions had lower TIR. CONCLUSION: While insulin dosing changed significantly with advancing gestation, most participants did not achieve >70% TIR. Customized anticipatory pump setting adjustments and automated systems aimed toward the designated TIR are needed to improve outcomes for this population. NCT03761615 ) Array ( [Name] => Language [Label] => Language [Group] => Lang [Data] => English ) Array ( [Name] => URL [Label] => Access URL [Group] => URL [Data] => <link linkTarget="URL" linkTerm="https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c8c0c21b28b4fe873ed934b6c5bbba25" linkWindow="_blank">https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c8c0c21b28b4fe873ed934b6c5bbba25</link><br /><link linkTarget="URL" linkTerm="https://europepmc.org/articles/PMC9057877/" linkWindow="_blank">https://europepmc.org/articles/PMC9057877/</link> ) Array ( [Name] => Copyright [Label] => Rights [Group] => Cpyrght [Data] => OPEN ) Array ( [Name] => AN [Label] => Accession Number [Group] => ID [Data] => edsair.doi.dedup.....c8c0c21b28b4fe873ed934b6c5bbba25 ) |
RecordInfo |
Array
(
[BibEntity] => Array
(
[Languages] => Array
(
[0] => Array
(
[Text] => English
)
)
[Subjects] => Array
(
[0] => Array
(
[SubjectFull] => Blood Glucose
[Type] => general
)
[1] => Array
(
[SubjectFull] => Pediatrics
[Type] => general
)
[2] => Array
(
[SubjectFull] => medicine.medical_specialty
[Type] => general
)
[3] => Array
(
[SubjectFull] => Endocrinology, Diabetes and Metabolism
[Type] => general
)
[4] => Array
(
[SubjectFull] => medicine.medical_treatment
[Type] => general
)
[5] => Array
(
[SubjectFull] => Longitudinal observation
[Type] => general
)
[6] => Array
(
[SubjectFull] => Endocrinology
[Type] => general
)
[7] => Array
(
[SubjectFull] => Pregnancy
[Type] => general
)
[8] => Array
(
[SubjectFull] => Diabetes mellitus
[Type] => general
)
[9] => Array
(
[SubjectFull] => medicine
[Type] => general
)
[10] => Array
(
[SubjectFull] => Humans
[Type] => general
)
[11] => Array
(
[SubjectFull] => Hypoglycemic Agents
[Type] => general
)
[12] => Array
(
[SubjectFull] => Insulin
[Type] => general
)
[13] => Array
(
[SubjectFull] => Glycemic
[Type] => general
)
[14] => Array
(
[SubjectFull] => Type 1 diabetes
[Type] => general
)
[15] => Array
(
[SubjectFull] => business.industry
[Type] => general
)
[16] => Array
(
[SubjectFull] => Blood Glucose Self-Monitoring
[Type] => general
)
[17] => Array
(
[SubjectFull] => Infant, Newborn
[Type] => general
)
[18] => Array
(
[SubjectFull] => Infant
[Type] => general
)
[19] => Array
(
[SubjectFull] => Original Articles
[Type] => general
)
[20] => Array
(
[SubjectFull] => medicine.disease
[Type] => general
)
[21] => Array
(
[SubjectFull] => INSULIN USE
[Type] => general
)
[22] => Array
(
[SubjectFull] => Medical Laboratory Technology
[Type] => general
)
[23] => Array
(
[SubjectFull] => Benchmarking
[Type] => general
)
[24] => Array
(
[SubjectFull] => Diabetes Mellitus, Type 1
[Type] => general
)
[25] => Array
(
[SubjectFull] => Female
[Type] => general
)
[26] => Array
(
[SubjectFull] => Pregnant Women
[Type] => general
)
[27] => Array
(
[SubjectFull] => Glucose monitors
[Type] => general
)
[28] => Array
(
[SubjectFull] => business
[Type] => general
)
)
[Titles] => Array
(
[0] => Array
(
[TitleFull] => Longitudinal Observation of Insulin Use and Glucose Sensor Metrics in Pregnant Women with Type 1 Diabetes Using Continuous Glucose Monitors and Insulin Pumps: The LOIS-P Study
[Type] => main
)
)
)
[BibRelationships] => Array
(
[HasContributorRelationships] => Array
(
[0] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Carol J. Levy
)
)
)
[1] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Barak Rosenn
)
)
)
[2] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Donna Desjardins
)
)
)
[3] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Jordan E. Pinsker
)
)
)
[4] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Corey Reid
)
)
)
[5] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Mei Mei Church
)
)
)
[6] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Yogish C. Kudva
)
)
)
[7] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Mari Charisse Trinidad
)
)
)
[8] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Kristin Castorino
)
)
)
[9] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Francis J. Doyle
)
)
)
[10] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Walter K. Kremers
)
)
)
[11] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Shelly K. McCrady-Spitzer
)
)
)
[12] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Eyal Dassau
)
)
)
[13] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Ravinder Kaur
)
)
)
[14] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Camilla Levister
)
)
)
[15] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Basak Ozaslan
)
)
)
[16] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Grenye O’Malley
)
)
)
)
[IsPartOfRelationships] => Array
(
[0] => Array
(
[BibEntity] => Array
(
[Dates] => Array
(
[0] => Array
(
[D] => 25
[M] => 11
[Type] => published
[Y] => 2021
)
)
[Identifiers] => Array
(
[0] => Array
(
[Type] => issn-locals
[Value] => edsair
)
[1] => Array
(
[Type] => issn-locals
[Value] => edsairFT
)
)
)
)
)
)
)
|
IllustrationInfo |